Clinical Research Directory
Browse clinical research sites, groups, and studies.
Naturally Controlled Decongestion Using Renal Independent System in ADHF Patients, a European Registry
Sponsor: AquaPass Medical Ltd.
Summary
The AquaPass is a non-invasive, renal-intended system designed to enhance fluid transfer through the skin, by increasing sweat rate, to treat fluid overload in heart failure patients. This study will further evaluate the safety, efficacy, and usability of the AquaPass system in the hospital and home settings.
Official title: Evaluating the Safety and Efficacy of the AquaPass System a Renal-independent Fluid Removal System in ADHF Patients Suffering From Fluid Overload. a European Registry
Key Details
Gender
All
Age Range
21 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-02
Completion Date
2026-05
Last Updated
2024-05-06
Healthy Volunteers
No
Interventions
AquaPass
The AquaPass system works by activating the body's natural sweating mechanism to remove excess fluid from the interstitial compartment. This process is achieved by wearing a garment that creates optimal microclimate conditions around the skin. The system is controlled by a portable unit that delivers warm air to the wearable component while ensuring patient safety.